Filter by Year:

October 22, 2024 | BIOPHARMA DIVE

State of Play – RNA editing: emerging from CRISPR’s shadow

October 22, 2024 | NIKKEI

RNA editing for cancer and other intractable diseases: safer than gene therapy, new clinical trial

To view the article in Japanese, click here.

October 8, 2024 | PHARMAVOICE

The 2024 PharmaVoice 100

September 26, 2024 | ENDPOINTS

Endpoints 11 winner Ascidian Therapeutics: A search-and-replace technology comes to RNA

August 5, 2024 | Fierce Biotech

Introducing Fierce Biotech’s 2024 Fierce 15

July 29, 2024 | Rare Insights Podcast

Rewriting RNA with Ascidian Therapeutics

June 24, 2024 | MedCity News

Roche Adds Another Neuro Alliance, Inking R&D Pact With RNA-Editing Startup Ascidian

June 20, 2024 | Scrip

Roche Adds Ascidian’s RNA-Writing To Its Neurology Push

June 18, 2024 | BioWorld

Deals bring $3B+ for Ascidian, Belharra, Mabcare

June 18, 2024 | FirstWord Pharma

Roche inks potential $1.8B neuro-focused RNA exon editing pact with Ascidian